
### [NCIT:C3720](http://purl.obolibrary.org/obo/NCIT_C3720)
**Label:** Anaplastic Large Cell Lymphoma

**Subclasses:** [NCIT:C7208](http://purl.obolibrary.org/obo/NCIT_C7208) (Small Cell Variant Anaplastic Large Cell Lymphoma), [NCIT:C8658](http://purl.obolibrary.org/obo/NCIT_C8658) (Refractory Anaplastic Large Cell Lymphoma), [NCIT:C8659](http://purl.obolibrary.org/obo/NCIT_C8659) (Stage I Anaplastic Large Cell Lymphoma), [NCIT:C115357](http://purl.obolibrary.org/obo/NCIT_C115357) (Recurrent Childhood Anaplastic Large Cell Lymphoma), [NCIT:C5322](http://purl.obolibrary.org/obo/NCIT_C5322) (Central Nervous System Anaplastic Large Cell Lymphoma), [NCIT:C115032](http://purl.obolibrary.org/obo/NCIT_C115032) (Stage IV Childhood Anaplastic Large Cell Lymphoma), [NCIT:C115031](http://purl.obolibrary.org/obo/NCIT_C115031) (Stage III Childhood Anaplastic Large Cell Lymphoma), [NCIT:C115030](http://purl.obolibrary.org/obo/NCIT_C115030) (Stage II Childhood Anaplastic Large Cell Lymphoma), [NCIT:C9471](http://purl.obolibrary.org/obo/NCIT_C9471) (Childhood Systemic Anaplastic Large Cell Lymphoma), [NCIT:C39674](http://purl.obolibrary.org/obo/NCIT_C39674) (Anaplastic Large Cell Lymphoma, Giant Cell Rich Subtype), [NCIT:C37196](http://purl.obolibrary.org/obo/NCIT_C37196) (Primary Systemic Anaplastic Large Cell Lymphoma, ALK-Negative), [NCIT:C37195](http://purl.obolibrary.org/obo/NCIT_C37195) (Primary Systemic Anaplastic Large Cell Lymphoma, ALK-Positive), [NCIT:C9470](http://purl.obolibrary.org/obo/NCIT_C9470) (Systemic Anaplastic Large Cell Lymphoma), [NCIT:C9250](http://purl.obolibrary.org/obo/NCIT_C9250) (Recurrent Anaplastic Large Cell Lymphoma), [NCIT:C129599](http://purl.obolibrary.org/obo/NCIT_C129599) (Central Nervous System Anaplastic Large Cell Lymphoma, ALK-Negative), [NCIT:C129598](http://purl.obolibrary.org/obo/NCIT_C129598) (Central Nervous System Anaplastic Large Cell Lymphoma, ALK-Positive), [NCIT:C27366](http://purl.obolibrary.org/obo/NCIT_C27366) (Adult Systemic Anaplastic Large Cell Lymphoma), [NCIT:C27365](http://purl.obolibrary.org/obo/NCIT_C27365) (Adult Primary Cutaneous Anaplastic Large Cell Lymphoma), [NCIT:C5636](http://purl.obolibrary.org/obo/NCIT_C5636) (Childhood Anaplastic Large Cell Lymphoma), [NCIT:C27367](http://purl.obolibrary.org/obo/NCIT_C27367) (Adult Anaplastic Large Cell Lymphoma), [NCIT:C115029](http://purl.obolibrary.org/obo/NCIT_C115029) (Stage I Childhood Anaplastic Large Cell Lymphoma), [NCIT:C6860](http://purl.obolibrary.org/obo/NCIT_C6860) (Primary Cutaneous Anaplastic Large Cell Lymphoma), [NCIT:C7211](http://purl.obolibrary.org/obo/NCIT_C7211) (Childhood Primary Cutaneous Anaplastic Large Cell Lymphoma), [NCIT:C37194](http://purl.obolibrary.org/obo/NCIT_C37194) (Anaplastic Large Cell Lymphoma, ALK-Negative), [NCIT:C8661](http://purl.obolibrary.org/obo/NCIT_C8661) (Stage III Anaplastic Large Cell Lymphoma), [NCIT:C37193](http://purl.obolibrary.org/obo/NCIT_C37193) (Anaplastic Large Cell Lymphoma, ALK-Positive), [NCIT:C8662](http://purl.obolibrary.org/obo/NCIT_C8662) (Stage IV Anaplastic Large Cell Lymphoma), [NCIT:C8660](http://purl.obolibrary.org/obo/NCIT_C8660) (Stage II Anaplastic Large Cell Lymphoma), 

**Class expressions from DL-Learner:**

- Thing 55.28%
- [NCIT:C39678](http://purl.obolibrary.org/obo/NCIT_C39678) (Anaplastic T-Lymphocyte) 52.13%
- [NCIT:C39678](http://purl.obolibrary.org/obo/NCIT_C39678) (Anaplastic T-Lymphocyte) and (not ([CL:1001576](http://purl.obolibrary.org/obo/CL_1001576) (oral mucosa squamous cell))) 52.13%
- [NCIT:C39678](http://purl.obolibrary.org/obo/NCIT_C39678) (Anaplastic T-Lymphocyte) and (not ([CL:1001575](http://purl.obolibrary.org/obo/CL_1001575) (uterine cervix squamous cell))) 52.13%
- [NCIT:C39678](http://purl.obolibrary.org/obo/NCIT_C39678) (Anaplastic T-Lymphocyte) and (not ([CL:1001573](http://purl.obolibrary.org/obo/CL_1001573) (nasopharyngeal epithelial cell))) 52.13%
- [NCIT:C39678](http://purl.obolibrary.org/obo/NCIT_C39678) (Anaplastic T-Lymphocyte) and (not ([CL:1001572](http://purl.obolibrary.org/obo/CL_1001572) (colon endothelial cell))) 52.13%
- [NCIT:C39678](http://purl.obolibrary.org/obo/NCIT_C39678) (Anaplastic T-Lymphocyte) and (not ([CL:1001568](http://purl.obolibrary.org/obo/CL_1001568) (pulmonary artery endothelial cell))) 52.13%
- [NCIT:C39678](http://purl.obolibrary.org/obo/NCIT_C39678) (Anaplastic T-Lymphocyte) and (not ([CL:1001567](http://purl.obolibrary.org/obo/CL_1001567) (lung endothelial cell))) 52.13%
- [NCIT:C39678](http://purl.obolibrary.org/obo/NCIT_C39678) (Anaplastic T-Lymphocyte) and (not ([CL:1001434](http://purl.obolibrary.org/obo/CL_1001434) (olfactory bulb interneuron))) 52.13%
- [NCIT:C39678](http://purl.obolibrary.org/obo/NCIT_C39678) (Anaplastic T-Lymphocyte) and (not ([CL:1001431](http://purl.obolibrary.org/obo/CL_1001431) (kidney collecting duct principal cell))) 52.13%
- [NCIT:C39678](http://purl.obolibrary.org/obo/NCIT_C39678) (Anaplastic T-Lymphocyte) and (not ([CL:1001430](http://purl.obolibrary.org/obo/CL_1001430) (urethra urothelial cell))) 52.13%
- [NCIT:C39678](http://purl.obolibrary.org/obo/NCIT_C39678) (Anaplastic T-Lymphocyte) and (not ([CL:1001428](http://purl.obolibrary.org/obo/CL_1001428) (bladder urothelial cell))) 52.13%
- [NCIT:C39678](http://purl.obolibrary.org/obo/NCIT_C39678) (Anaplastic T-Lymphocyte) and (not ([CL:1001318](http://purl.obolibrary.org/obo/CL_1001318) (renal interstitial pericyte))) 52.13%
- [NCIT:C39678](http://purl.obolibrary.org/obo/NCIT_C39678) (Anaplastic T-Lymphocyte) and (not ([CL:1001052](http://purl.obolibrary.org/obo/CL_1001052) (kidney cortex vein cell))) 52.13%
- [NCIT:C39678](http://purl.obolibrary.org/obo/NCIT_C39678) (Anaplastic T-Lymphocyte) and (not ([CL:1001045](http://purl.obolibrary.org/obo/CL_1001045) (kidney cortex artery cell))) 52.13%


